Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma

NCT05532397 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Glioma, Astrocytic

Interventions

DRUG: QPOP category 1
DRUG: QPOP category 2

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]